NRGene

Genomics Solutions for Agricultural Breeders

Agriculture & Food Technologies
Public on TASE on Jan, 2021<br>
Follow

Company Overview

Snapshot

Founded in February 2009 by Gil Ronen and Guy Kol, NRGene operates with 11–50 employees. The company has raised $42.3M across four funding rounds and went public on TASE in January 2021, raising $30.6M.

Business overview

NRGene is a genomics company that delivers turn-key software solutions for agricultural breeding enterprises. Leveraging advanced algorithms and extensive proprietary databases, the company empowers breeders to achieve superior quality and higher yield productivity. NRGene's technology has been applied to assemble over 500 genomes across dozens of species, including wheat, corn, soy, tomato, cannabis, cattle, and rainbow trout. The company serves agricultural biotechnology firms and academic research teams globally, operating within the Agriculture & Food Technologies sector with a focus on genetics, smart farming, and bioinformatics.

Strategic signal

In March 2026, NRGene Canada launched MaxBites™, a premium pet treat derived from Black Soldier Fly larvae, marking the company's entry into the North American pet nutrition market. This strategic move diversifies NRGene's product portfolio beyond its core genomics solutions for crop improvement, signaling an expansion into new commercial verticals and leveraging its expertise in sustainable agricultural inputs for broader market applications.

Log in to access full profile

Company Intelligence Q&A

What was a significant recent product launch for NRGene?
In March 2026, NRGene Canada launched MaxBites™, a premium pet treat made from 100% dried Black Soldier Fly larvae, entering the North American pet nutrition market.
What recent breakthrough did NRGene announce in canola breeding?
In September 2025, NRGene achieved full clubroot resistance in canola through field trials and is moving towards commercialization in Canada, utilizing its AI-driven genomics for crop improvement.
Has NRGene achieved commercialization for any of its disease-resistant crops?
Yes, in September 2025, NRGene announced the first successful commercialization of tomato seeds carrying its High Resistance (HR) trait to Tomato Brown Rugose Fruit Virus (ToBRFV).
What was a key strategic partnership for NRGene in 2023?
In September 2023, NRGene collaborated with Bühler to enhance the competitiveness of the black soldier fly industry, focusing on increasing efficiency and sustainability.
When did NRGene go public and on which exchange?
NRGene went public on the TASE (Tel Aviv Stock Exchange) in January 2021, raising $30.6M.
Log in to access full profile